France · Series C startup

Who invested in ENYO Pharma

2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$54Mraised across 2 rounds since 2018, from 2 sources

$47MSeries B$6.9MSeries C
Latest round
Series C, $6.9MJun 2025
Biggest round
$47MSeries B · Jun 2018
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182019202020212022202320242025
$47MSeries B$6.9MSeries C
First round
Series B, $47M
Jun 2018
Biggest round
$47M
Series B · Jun 2018
Between rounds
7 years
from the last two

The rounds

  1. Jun 2025
    Series C$6.9M4 new

    Source recorded

  2. Jun 2018
    Series B$47M6 new

    Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

BpifranceGovernment1round
OrbiMedPrivate equity1round
Sofinnova PartnersVC firm1round
Morningside GroupVC firm1round
Andera PartnersPrivate equity1round
Inserm Transfert InitiativeInvestment firm1round
Bpifrance Largeno record of our own yet1round
InnoBiono record of our own yet1round
OrbiMed/ Anderano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ENYO Pharma

Who invested in ENYO Pharma?

ENYO Pharma's investors include Bpifrance, OrbiMed, Sofinnova Partners, Morningside Group and Sofinnova Investments, and 5 more on record.

How much has ENYO Pharma raised?

ENYO Pharma has raised $54M across 2 rounds since 2018.

When did ENYO Pharma last raise?

ENYO Pharma's most recent round was a Series C of $6.9M in Jun 2025.

What was ENYO Pharma's biggest round?

ENYO Pharma's largest round on record is $47M (Series B), in Jun 2018.

Who backed ENYO Pharma first?

ENYO Pharma's first round on record, in Jun 2018, was backed by Morningside Group, Sofinnova Investments and Inserm Transfert Initiative and 3 others.

What stage is ENYO Pharma at?

ENYO Pharma's latest named round is a Series C, in Jun 2025.

Where is ENYO Pharma based?

ENYO Pharma is based in France.

Companies like ENYO Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.